Apr 23, 2025, 01:00 by User Not Found

Clinical Research News | Researchers have identified "left atrial reservoir strain" as the best biomarker for predicting stroke and dementia risk, according to a new study published in the journal Stroke. The research, led by Dr. Lin Yee Chen of the University of Minnesota Medical School, compared various methods of detecting left atrial (LA) myopathy, an abnormality of the heart's left atrium that can indicate elevated risk even without atrial fibrillation (AFib).

Apr 22, 2025, 08:13 by

Symbiosis Pharmaceutical Services, a specialist sterile manufacturing CMO, who has been formally recognised by EcoVadis for its continued commitment to sustainability.

Apr 18, 2025, 01:00 by User Not Found

Clinical Research News | As life sciences companies increasingly embrace artificial intelligence and digital transformation, quality assurance and regulatory affairs professionals face opportunities and challenges. The journey from paper-based systems to AI-driven solutions requires careful consideration of the various factors required to ensure successful implementation while maintaining global compliance and product quality to ensure the provision of safe and effective patient solutions and treatments.

Apr 16, 2025, 06:40 by

VieCure is making thousands of the most commonly used NCCN Chemotherapy Order Templates available on its Halo Intelligence Platform

Apr 16, 2025, 06:40 by

CluePoints, provider of leading statistical and AI-driven software solutions, has been named as a finalist in the ‘Innovative Clinical Trial Solutions’ category at the 2025 Citeline Awards.

Apr 15, 2025, 06:36 by

Apr 15, 2025, 06:36 by

Oxford Nanopore Technologies announced the expansion of its Compatible Products Program. New participating companies include: 10x Genomics, Agilent Technologies, Asuragen, Day Zero Diagnostics, Hamilton Robotics, NEB, Opentrons, Pathosense, and Thermo Fisher Scientific.

Apr 15, 2025, 06:36 by

The launch of a new mid-sized CDMO, Meribel Pharma Solutions, bringing together 10 manufacturing sites and 3 development centres across Europe. The team – including ex-Synerlab and Catalent leadership – aims to offer agile, high-quality solutions across OSD, sterile, and semi-solid manufacturing. Built on a strong legacy, the company is filling a much-needed niche in the market with centres of excellence in lyophilisation, preservative-free multidose tech, and more.

Apr 15, 2025, 01:00 by User Not Found

Clinical Research News | Understanding the trajectory of a disease, including how it developed in the first place, is a bit like reconstructing a crime scene where scientists piece together fragmented information in hopes of mapping out the sequence of events and identifying the culprit. But critical connections can be made by analyzing multi-omics data linked to disease and registry data and turning them into actionable insights at the point of care.

Apr 11, 2025, 08:08 by

High Force Research, a leading UK-based provider of specialist chemical R&D and manufacturing services has just appointed Dr. Nathalie Huther as its first-ever Chief Commercial Officer following a recent management buyout. This is a pivotal moment for the company, as it gears up to accelerate growth and deepen its presence in the pharmaceutical, biotech, and specialty chemicals markets. Nathalie brings 15+ years of commercial leadership experience across the chemical and life sciences sectors and will be steering High Force Research’s business development and market expansion strategy.

Apr 11, 2025, 08:08 by

EMAS Pharma has officially rebranded as Evestia Clinical, signaling a bold new chapter as a specialised Contract Research Organization (CRO) dedicated to oncology and rare disease clinical trials. With the backing of Kester Capital and a leadership team with a proven track record, Evestia Clinical is set to redefine the clinical research landscape by delivering agile, expert-driven solutions to biotech innovators worldwide. With a rapidly growing demand for faster, more adaptive trials in complex therapeutic areas, this transformation comes at a critical time for the industry. The new identity underscores the company’s commitment to accelerating life-changing therapies to market while strengthening its strategic partnerships with biotech firms globally.

Apr 11, 2025, 08:08 by

Phastar, a global specialist biometrics & data science Contract Research Organization (CRO), has been shortlisted in the ‘CRO Partnership of the Year’ category at the 2025 Citeline Awards for its collaboration with Medicines Development for Global Health (MDGH), a not for profit pharmaceutical company dedicated to the development of affordable medicines for the people who need them most.

Apr 11, 2025, 01:00 by User Not Found

Clinical Research News | Clinical trial complexity is at an all-time high, with today’s clinical trials being more complex in their design and execution, whilst also demanding more sophisticated data management, regulatory navigation, and operational coordination than trials conducted a decade ago.

Apr 10, 2025, 08:39 by

Cepheid and Oxford Nanopore Technologies announce new collaboration to develop an integrated sequencing workflow to advance infectious disease analysis.

Apr 10, 2025, 08:39 by

News from Cellistic, which has launched its new Echo™-NK platform to support the production of off-the-shelf Natural Killer cell therapies. The platform offers a cost-effective, GMP-compliant solution for scaling iPSC-derived NK cells, aimed at treating cancers and autoimmune diseases. It also integrates Cellistic’s STAR-CRISPR and Pulse technologies to help speed up development, with several client projects already in progress.

Apr 10, 2025, 01:00 by User Not Found

Clinical Research News | As a longtime electronic health record (EHR) supplier for ambulatory care providers, Veradigm (formerly Allscripts) finds itself at the “intersection of research and patient care” with the wherewithal to offer medical practitioners research opportunities and clinical trial sponsors real-world data and solutions to support their R&D ambitions.

Apr 9, 2025, 08:11 by

Apr 9, 2025, 08:11 by

Building on a decade of research and validation, study leverages precision, phenotype-guided treatment for enhanced patient outcomes on GLP-1s.

Apr 9, 2025, 08:11 by

Upperton Pharma Solutions, a leading UK-based contract development and manufacturing organisation (CDMO), continues its growth following the build of a new sterile manufacturing facility with the appointment of Michael Mellor-Clark as Chief Commercial Officer (CCO).

Apr 9, 2025, 01:00 by User Not Found

Clinical Research News | This month’s episode of the Scope of Things covers the latest news on setting expectations for Phase II cancer trials, insights about dementia from the Nun Study, and more, brought to you by host Deborah Borfitz. Ravi Parikh, medical director of data and technology applications shared resource at Winship Cancer Institute of Emory University, joins in to discuss TrialTranslator.